Related Experiment Videos
[Waldenström macroglobulinemia with diffuse large B-cell lymphoma that developed from a different B-cell clone]
1Fourth Department of Internal Medicine, Sapporo Medical University School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 24, 1999
Summary
This case study reveals a patient initially diagnosed with Waldenström macroglobulinemia (WM) who later developed diffuse large B-cell lymphoma. Genetic analysis confirmed the lymphoma was an independent B-cell malignancy, not a progression of WM.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Waldenström macroglobulinemia (WM) is a rare, slow-growing lymphoma of B-cell origin.
- Distinguishing secondary malignancies from disease progression in WM is clinically significant.
Observation:
- A 62-year-old male with WM developed symptoms including fever and weight loss.
- Imaging revealed multiple masses in the liver, adrenal region, and kidney hilum.
- Liver biopsy confirmed diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin's lymphoma.
Findings:
- Immunoglobulin heavy chain gene rearrangement analysis showed distinct patterns between the initial WM and the subsequent DLBCL.
- This genetic divergence indicated two separate B-cell malignancies.
- The patient's lymphoma showed poor response to chemotherapy and was ultimately fatal.
Implications:
- This case highlights the importance of molecular diagnostics in differentiating superimposed lymphomas from disease progression in WM.
- Accurate diagnosis is crucial for appropriate therapeutic strategies and patient management.
- Understanding distinct clonal origins can inform prognosis and treatment selection for complex hematologic malignancies.